See what questions
a doctor would ask.
AstraZeneca has withdrawn its application to market the small cell lung cancer drug, Iressa in Europe. Initial trials of the drug found produced a statistically significant reduction in tumor size but further trials showed that it did not necessarily deliver any worthy survival benefits. The company has reaffirmed its belief in the safety of the cholesterol drug Crestor which has recently been under scrutiny.
Source: summary of medical news story as reported by News Scotsman
About: Drug company stops marketing plans for new lung cancer drug due to poor trial results
Date: 4 January 2005
Source: News Scotsman
Author: Lyndsay Moss
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City